pharmacokinetics(3) polycythemia vera(1) receptor(1) Hematopoietic cell transplant(1) Drug development–phase 1(1) Thiotepa(1) myeloproliferative neoplasm(1) Platelet-derived growth factor alpha(1) Busulfan(1) HSCT(1) JAK inhibition(1) Neoplasms(1) Fludarabine(1) Drug development–randomized controlled trial(1) ruxolitinib(1) Platelet(1) Biomarkers(1) Clinical pharmacology–drug safety(1) TEPA(1) myelofibrosis(1) Clinical trial, phase I(1) Therapeutic Drug Monitoring(1)